ASB2 p.Asp558Asn
c.1672G>A · rs567814586 · VCV2593468
Computational evidence
| Protein change | ||
| AlphaMissense | 0.723 | likely pathogenic |
|---|---|---|
| REVEL | 0.357 | indeterminate |
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 7.7 | phastCons 1 |
| Regional constraint | o/e 1.05 | unconstrained · MANE · 30 kb · p 0.18 · regional, not allelic |
| Overall | ||
| CADD | 32.0 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
⚠ Isoform check: AlphaMissense numbered on a different transcript (AM D510N vs ClinVar D558N) — verify the residue.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| South Asiangrpmax | 0.00989% | 10,111 |
| African / African-American | 0.008% | 12,502 |
| East Asian | 0.00223% | 44,798 |
| European (non-Finnish) | 0.00034% | 294,500 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- ASB2
- Protein
- p.Asp558Asn
- Coding
- c.1672G>A
- MANE Select
- NM_001202429
- dbSNP
- rs567814586
- Type
- single nucleotide variant
- Location
- chr14:93937797 (GRCh38)
- Gene constraint
- LOEUF 1.243 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 83.96
Similar variants
- ASB2 p.Ala132Thr Uncertain significance ★ ⚠ same type
- ASB2 p.Ala196Thr Uncertain significance ★ same type
- ASB2 p.Ala212Asp Uncertain significance ★ ⚠ same type
- ASB2 p.Ala229Thr Uncertain significance ★ ⚠ same type
- ASB2 p.Ala269Thr Uncertain significance ★ ⚠ same type
- ASB2 p.Ala305Thr Uncertain significance ★ ⚠ same type
- ASB2 p.Ala330Thr Uncertain significance ★ ⚠ same type
- ASB2 p.Ala376Pro Uncertain significance ★ ⚠ same type
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/asb2-p-asp558asn (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown